In this workshop, participants will discuss clinical endpoints relevant to NPC clinical trials and innovative strategies to support therapeutic development for patients with NPC. January 24, 2022 - 12:00pm - 3:30pm January 25, 2022 - 12:00pm - 3:30pm You may submit comments for this workshop to Docket FDA-2021-N-1297. Docket open until 4/25/22